|
FY2026
12 months to Jan 31, 2026
|
FY2025
12 months to Jan 31, 2025
|
|
|---|---|---|
| Cash flows provided by (used in) operating activities | ||
| Net loss | ||
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities | ||
| Depreciation and amortization expense | ||
| Amortization of deferred contract costs | ||
| Non-cash operating lease expense | ||
| Stock-based compensation expense | ||
| Loss on impairment and disposal of assets | ||
| Change in valuation of contingent consideration | ||
| Deferred income taxes | ||
| Amortization of debt issuance costs | ||
| Loss on extinguishment of debt | ||
| Provision for credit losses | ||
| Changes in operating assets and liabilities, net of effect of business acquisition: | ||
| Accounts receivable | ||
| Prepaid expenses and other current assets | ||
| Deferred contract costs | ||
| Contract assets | ||
| Other assets | ||
| Accounts payable and other accrued expenses | ||
| Accrued personnel related expenses | ||
| Operating lease liabilities | ||
| Other liabilities | ||
| Deferred revenue | ||
| Net cash provided by (used in) operating activities | ||
| Cash flows provided by (used in) investing activities | ||
| Capitalized internal-use software | ||
| Purchase of property and equipment | ||
| Deposits for property and equipment | ||
| Acquisition of business, net of cash acquired | ||
| Net cash used in investing activities | ||
| Cash flows provided by (used in) financing activities | ||
| Payment of contingent consideration | ||
| Proceeds from exercise of stock options | ||
| Proceeds from issuance of common stock in initial public offering, net of underwriting costs | ||
| Repayment of non-convertible preferred stock | ||
| Payment of debt arrangements | ||
| Payment of deferred initial public offering costs | ||
| Costs associated with initial public offering | ||
| Shares repurchased for tax withholding for the settlement of restricted stock units | ||
| Net cash provided by (used in) financing activities | ||
| Net increase (decrease) in cash, cash equivalents, and restricted cash | ||
| Beginning of period | ||
| End of period | ||
| Supplemental disclosures of other cash flow information: | ||
| Cash paid for interest expense | ||
| Cash paid for amounts included in the measurement of lease liabilities | ||
| Cash paid for income taxes | ||
| Tenant improvements received from lessor | ||
| Noncash investing and financing activities: | ||
| Issuance of common stock in consideration for business acquisition | ||
| Capitalized internal-use software additions included in accrued expenses | ||
| Stock-based compensation capitalized in internal-use software | ||
| Property and equipment purchases included in accounts payable and accrued expenses | ||
| Reclassification from liabilities to additional paid-in capital upon vesting of early exercised stock options | ||
| Conversion of preferred stock to common stock | ||
| Costs associated with initial public offering included in accrued expenses | ||
| Right-of-use assets obtained in exchange for lease obligations | ||
| Reduction in right-of-use asset and lease liability due to reduction in lease payments | ||
| Reduction in right-of-use asset and lease liability due to lease modifications | ||
| Change in asset retirement obligations | ||
| Accretion of non-convertible preferred stock | ||
| Series H Redeemable Convertible Preferred Stock | ||
| Total accretion of non-convertible preferred stock | ||
| Reconciliation of cash, cash equivalents, and restricted cash within consolidated balance sheets: | ||
| Cash and cash equivalents | ||
| Restricted cash |
Loading...
